Biosino Biotechnology Company Ltd is a high-technology enterprise whose major national controlling stakeholders comprise the Chinese Academy of Sciences, Beijing Municipal Government and Shanghai Municipal Government. Through the development, production and retail of diagnostic products, Biosino has become the largest manufacturer of diagnostic biochemical assay kits in China. Formerly established in 1988 as Beijing Zhong Sheng Bio-engineering High Technology Company, it was a national enterprise under the auspices of the Chinese Academy of Sciences Institute of Biophysics. In 2001, the Chinese Academy of Sciences Institute of Biophysics backed the re-launch of the company. With investment from Chuangkou Enterprises in Hong Kong owned by Beijing Municipal Government and from Shanghai Municipal Government's Lianchuang Investment Company, together with a new name, Biosino Biotechnology Company Ltd. was established.

Since its inception, Biosino has taken the lead within China in creating a series of mono- and double- reagent diagnostic products, successfully developing a series of more than 90 assay sets directed at conditions such as hepatitis, coronary artery disease, diabetes and hyperlipidemia. Our series of over 200 standard mono- and double- reagent diagnostic tests has been consistently recognized over the years to be a leading product from the Beijing New Technology Pilot Industrial Development Zone. What is more, our enterprise has been listed as one of the top 50 "New Technology Tigers", achieving recognition for our products as a famous brand nationally.

In 1989, our series of diagnostic chemical assay kits won the Chinese Academy of Sciences' Science and Technology Award (3rd level) and the Development Zone's Outstanding Achievement Award. In 1993, Biosino became the first company in China to produce double-reagents for use in automated equipment, gaining national recognition for reagents approved for use with the Hitachi fully automated biochemical analyzer. Biosino's double-reagent products are now well established and widely used with Hitachi, Olympus, Beckman and other such analyzers, used in major centers and well-received by customers. With over a dozen years of development, Biosino's products are now promoted by over 500 agents and retailers, occupy 75% of the market and enjoy a retail network that covers the whole country.

The company has built a new factory, strictly in accordance with GMP standards, which boasts the best facilities in China. Using advanced international production technology and management models, we have achieved a microcomputer-controlled, automated biochemical technology production system. In 2002, the company passed the ISO9001 quality inspection. Ever since it was founded, the company has always maintained its healthy momentum towards continued development, annual growth and stable expansion in marketing, becoming one of the leading names in biomedical enterprise at the Chinese Academy of Sciences as well as in Beijing.

First Class Facilities

In 1999, Biosino became the first to establish a microcomputer-controlled automated production line in China. Moreover, the new facility was made strictly according to GMP standards. In order to ensure consistently high quality, the company is equipped with leading brands of fully automated biochemical analyzers (Hitachi 7060 and Olympus 400), the KFL 180 dry powder filler,the automatic filler linked with capping, the LGT 5X lyophilizer and the British-made "Minifast" lyophilizer ¨C all first class equipment available in China. We have also introduced from America a water super-purification unit and purified water management system. These products, along with the most advanced production technology and management methods, enable Biosino to ensure that our clinical diagnostic products always meet every quality standard.

First Class Organization

Biosino's management, research and development, production and sales teams make up a staff of nearly 200 personnel, of whom 52% have received higher education. 50 of our staff hold a university degree, which includes 80% of our management team. A number of our staff are well-known academics who have returned to China after study overseas. The company comprises fifteen departments, responsible for the major areas of business strategy, project investment, research and development, production and sales. This professional, reliable team, full of vitality, by developing a spirit of innovation and teamwork, have made good use of the generous funding and excellent facilities available to create success which is characteristic of Biosino in the market, in research and development and in business achievement.

First Class Product Quality

As one of the largest providers of biochemical diagnostic supplies for medical use in China, Biosino uses an international-standard management system, a microcomputer network and automated production line technology to achieve a completely sealed, sterile, temperature-controlled and humidity-controlled environment. At the same time, in strict accordance with the requirements of quality control standards ISO9001 and YY/T0287, we employ meticulous and experienced personnel working in quality control, technological quality safeguards and production technology operations, in order to watch over the entire production process and establish an excellent, effective quality control system. Through consultation at international level meetings, we have developed a system of internal quality control within the production process, to ensure product uniformity and stability both within and between batches. This means that our products meet or surpass the requirements of China's National Drug Administration for reproducibility, stability and purity.

In 1989, the clinical diagnostic chemical sets developed by our company won the Chinese Academy of Sciences "Progress in Science and Technology Award" (Third Class) as well as the Beijing New Technology Pilot Industrial Development Zone "Outstanding Science and Technology Achievement Award".

Over the years since 1990, our clinical diagnostic series has consistently been found to be a leading product from Beijing's New Technology Pilot Industrial Development Zone.

In 2002, the company's in vitro clinical diagnostic reagents were again reviewed by the Beijing Technology Quality Control Office and judged to be a renowned Beijing brand.

First Class Service

In pursuing our aim to serve through technology, Biosino has especially developed its service department, with the appointment of first-rate pharmacologists, medical experts and sales staff. Every year we conduct market research and after-sales enquiries. By means of training classes, scientific seminars, information in periodicals such as the Chinese "Journal of Experimental Medical Technology" as well as information on the internet, we provide on-the-spot technological support and service to our customers, resolving queries or questions about the use of our products. We aim to provide the best service at the earliest opportunity.

Future Development

With the opportunities and challenges facing the world of biology, Biosino will continue to draw on the latest international technological developments in the sphere of clinical diagnostics, working with our characteristic strengths to incorporate and innovate, continually developing new skills and creating new products and so raising the competitive strength of Biosino. Already our products have entered the market across South-East Asia. Our objective is, through the collective effort and team spirit of our personnel, to realize a global market for our products and to see Biosino ranked among the world's best-known brands.